KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Enterprise Value (2017 - 2025)

Historic Enterprise Value for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$21.6 million.

  • Bionano Genomics' Enterprise Value fell 920.48% to -$21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.6 million, marking a year-over-year decrease of 920.48%. This contributed to the annual value of -$20.2 million for FY2024, which is 6978.78% up from last year.
  • Per Bionano Genomics' latest filing, its Enterprise Value stood at -$21.6 million for Q3 2025, which was down 920.48% from -$16.5 million recorded in Q2 2025.
  • Bionano Genomics' Enterprise Value's 5-year high stood at -$16.5 million during Q2 2025, with a 5-year trough of -$362.1 million in Q1 2021.
  • Over the past 5 years, Bionano Genomics' median Enterprise Value value was -$77.1 million (recorded in 2023), while the average stood at -$127.9 million.
  • Per our database at Business Quant, Bionano Genomics' Enterprise Value crashed by 434621.81% in 2021 and then soared by 7218.73% in 2024.
  • Bionano Genomics' Enterprise Value (Quarter) stood at -$250.6 million in 2021, then surged by 54.84% to -$113.2 million in 2022, then surged by 41.01% to -$66.8 million in 2023, then surged by 69.79% to -$20.2 million in 2024, then fell by 7.15% to -$21.6 million in 2025.
  • Its Enterprise Value stands at -$21.6 million for Q3 2025, versus -$16.5 million for Q2 2025 and -$18.2 million for Q1 2025.